The most striking signal ahead of EHTH's May 7 earnings print isn't in the options market — it's from the executive suite, where the CEO loaded up on shares just two months ago at prices close to where the stock trades today.
CEO Derrick Duke purchased nearly 188,000 shares at $1.38 each in late February, a $259,000 outlay that now sits near break-even with the stock at $2.00. CFO John Dolan followed in early March with a 25,000-share purchase at $1.53. Both trades carry a significance score of 3, the highest in the recent insider log. The net insider position over the past 90 days is a positive $348,000 across around 244,000 shares — meaningful for a company with a market cap at this level. The buys are partially offset by small programmatic sells in April from the CFO, General Counsel, and a chief-level officer, but those transactions totalled just a few thousand dollars each and look routine in character.
The short-selling picture is relaxed rather than aggressive. Short interest has eased about 7% over the past week to 5.7% of the free float — meaningful but not extreme. Borrow costs are low at 0.55%, and availability in the lending pool is wide, with utilization at just 4.6% against a 52-week high of 10.75%. That combination — declining short interest and cheap, plentiful borrow — points to no meaningful squeeze pressure. Options positioning is mildly elevated: the put/call ratio of 0.038 runs about 1.5 standard deviations above its 20-day average, but in absolute terms the ratio remains extraordinarily low, suggesting call-dominant positioning rather than any real hedging activity.
The bull/bear debate hinges on the trajectory of Medicare Advantage lifetime values and member retention. Bears point to a 4.7% year-over-year decline in MA LTV, now at $907, and expected AEP turnover that clouds revenue visibility. Bulls counter with a 13.8% jump in approved members — including 25.7% growth in Medicare Advantage — and a 21.7% revenue increase to $113.1M that beat estimates. Both data points reflect Q4 2025 results; the key question for today's print is whether those member gains are holding, and whether LTV assumptions have stabilised. Analysts have offered little comfort: RBC cut its target from $9 to $3 in March while staying at Sector Perform, and Craig-Hallum moved to Hold after the last print. The consensus mean target of $2.25 sits close to the current price, suggesting the Street sees limited near-term upside but equally limited downside from here. EPS momentum, however, ranks in the 99th percentile on a 90-day basis — the highest possible reading — and forward EPS growth expectations are in the 78th percentile, hinting that estimate revisions have turned sharply positive ahead of the release.
The last earnings event in February sent the stock down 31% in a single day, a reset that now frames the entire setup. Today's print tests whether the member growth and cost discipline highlighted in the bull case can overwrite the LTV and retention concerns that drove that selloff — and whether the CEO's conviction buy near these levels reflected private confidence or simply a well-timed floor.
See the live data behind this article on ORTEX.
Open EHTH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
